The clinicopathologic features of six cases of primary malignant cervical lymphoma.
- Author:
Kun Young KONG
1
;
Youg Soon KWON
;
Ga Won CHOI
;
Ae Ra HAN
;
Jun Woo AHN
;
Hang Jo YOO
;
Yong Man KIM
;
Young Tak KIM
;
Joo Hyun NAM
Author Information
1. Department of Obstetrics & Gynecology, Unversity of Ulsan, Asan medical center, Seoul, Korea. yskwon@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Primary malignant lymphoma;
Uterine cervix
- MeSH:
Cervix Uteri;
Diagnosis;
Drug Therapy;
Female;
Humans;
Hysterectomy;
Incidence;
Lymph Node Excision;
Lymph Nodes;
Lymphoma*;
Medical Records;
Ovariectomy;
Ovary;
Papanicolaou Test;
Recurrence;
Retrospective Studies;
Uterine Hemorrhage
- From:Korean Journal of Obstetrics and Gynecology
2007;50(11):1485-1492
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To provide clinical information for the best diagnosis and treatment of primary malignant cervical lymphoma based on the information obtained from these cases. METHODS: Between 1989 and 2006, six women with primary malignant cervical lymphoma were diagnosed and treated at our institution. Data were obtained from their medical records and were retrospectively analyzed. RESULTS: The mean patient age at the time of diagnosis was 63 (range 19-74). The chief complaint was vaginal bleeding in five women and the voiding difficulty for one woman. five of six patient had the cervical lesions (erosion and tumoral mass), while the other was non specific cervical findings. The Papanicolaou test was performed on three women, one of whom was HSIL. All six patients were confirmed with cervical lymphoma through the pathologic diagnosis. Surgical treatment (radical hysterectomy with bilateral salpingo- oophorectomy, pelvic lymph node dissection, and para-aortic lymph node dissection) was performed in one case, simple hysterectomy with complementary chemotherapy in two, and chemotherapy in one. Two patients refused treatment. Among four patients treated, one experienced recurrence in an ovary and the others have remained in remission. CONCLUSION: Primary malignant cervical lymphoma is a rare malignancy. Physicians can miss early detection of this disease because of its 'silent' symptoms and very low incidence. The accumulated data regarding this tumor can make it easy to detect at an early stage, thereby allowing it to be successfully treated. Further studies should be conducted to obtain further information regarding the cervical lymphoma.
